(ZEAL) Zealand Pharma - Performance -61.7% in 12m
ZEAL performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
16.64%
#22 in Peer-Group
Rel. Strength
6.39%
#7185 in Stock-Universe
Total Return 12m
-61.73%
#149 in Peer-Group
Total Return 5y
50.46%
#22 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | DKK |
|---|---|
| 52 Week High | 954.00 DKK |
| 52 Week Low | 353.40 DKK |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 38.80 |
| Buy/Sell Signal +-5 | 1.67 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: ZEAL (-61.7%) vs XBI (-7%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
0.07% | 70.8% | 77.8% | 22.7 | 13.6 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-9.1% | -6.38% | 147% | 11.3 | 10.5 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
2.72% | -1.16% | 36% | 25.4 | 13.4 | 0.93 | 0.60% | 41% |
| BIM PA Biomerieux |
1.34% | 27.6% | -4.82% | 33.1 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
3.69% | -7.17% | 1.14% | 43 | 24.8 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
18.3% | 43% | -4.19% | 27.6 | 22.4 | 0.9 | 68.9% | 36.8% |
| PTCT NASDAQ PTC Therapeutics |
-4.03% | 58.7% | -9.25% | 7.71 | 6.26 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
6.2% | 28.7% | 15.2% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: ZEAL vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for ZEAL
| Total Return (including Dividends) | ZEAL | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -22.06% | 3.36% | 4.68% |
| 3 Months | -14.78% | 15.73% | 24.35% |
| 12 Months | -61.73% | -7.02% | 14.02% |
| 5 Years | 50.46% | -24.21% | 111.83% |
| Trend Score (consistency of price movement) | ZEAL | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -82.2% | 4.4% | 81% |
| 3 Months | -47.7% | 78.8% | 96.9% |
| 12 Months | -95.2% | -85.8% | 44.9% |
| 5 Years | 70% | -52.6% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th7.50 | -24.59% | -25.95% |
| 3 Month | %th16.50 | -26.37% | -31.35% |
| 12 Month | %th26.50 | -58.84% | -66.47% |
| 5 Years | %th90.50 | 98.52% | -28.97% |
FAQs
Does Zealand Pharma (ZEAL) outperform the market?
No,
over the last 12 months ZEAL made -61.73%, while its related Sector, the SPDR S&P Biotech (XBI) made -7.02%.
Over the last 3 months ZEAL made -14.78%, while XBI made 15.73%.
Performance Comparison ZEAL vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
ZEAL vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -0.3% | -26.7% | -54.1% | -76% |
| US NASDAQ 100 | QQQ | -0.5% | -27.4% | -54.8% | -74% |
| German DAX 40 | DAX | 1.4% | -20.7% | -66.3% | -91% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 0.2% | -25.4% | -57.6% | -82% |
| Hongkong Hang Seng | HSI | -0.6% | -27.5% | -73.6% | -103% |
| India NIFTY 50 | INDA | 1.1% | -25.5% | -54.5% | -61% |
| Brasil Bovespa | EWZ | -0.7% | -29.8% | -79.2% | -72% |
ZEAL vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 0.6% | -28% | -58.3% | -86% |
| Consumer Discretionary | XLY | -0.3% | -25.2% | -46.5% | -80% |
| Consumer Staples | XLP | -1.1% | -22.7% | -55.8% | -71% |
| Energy | XLE | -1.1% | -29.1% | -50% | -62% |
| Financial | XLF | -1.5% | -27.1% | -59.1% | -92% |
| Health Care | XLV | -0.2% | -24.2% | -46.8% | -57% |
| Industrial | XLI | -0.9% | -26.3% | -62% | -87% |
| Materials | XLB | -3% | -26.3% | -58.7% | -68% |
| Real Estate | XLRE | -0.7% | -23% | -53.9% | -75% |
| Technology | XLK | -1.5% | -30.8% | -56.5% | -73% |
| Utilities | XLU | 0.3% | -23.9% | -57.4% | -85% |
| Aerospace & Defense | XAR | 1.4% | -29.1% | -72.7% | -111% |
| Biotech | XBI | -1.8% | -25.4% | -40.9% | -55% |
| Homebuilder | XHB | -3.3% | -29.1% | -47% | -67% |
| Retail | XRT | -3.3% | -27.1% | -49.8% | -73% |
ZEAL vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | -1.7% | -30.5% | -45.8% | -54% |
| Natural Gas | UNG | 8.7% | -12.2% | -37.4% | -59% |
| Gold | GLD | 0.2% | -22.7% | -74.8% | -103% |
| Silver | SLV | -1.8% | -29% | -71.5% | -79% |
| Copper | CPER | 0.1% | -27.6% | -71.2% | -74% |
ZEAL vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 1.1% | -23.1% | -50.7% | -60% |
| iShares High Yield Corp. Bond | HYG | 0.8% | -23.9% | -53% | -72% |